Ramani concluded that a soft extracellular matrix adversely alters redox homeostasis in metastatic breast cancer cells and that targeting this mechanotransduction pathway using Drp1 inhibitors, such as Drpitor1a, may constitute a new approach to prevent chemotherapy resistance [184]. Here, DNM1L is linked to breast carcinoma.